The short version
- Why people research itAround-the-clock GH/IGF-1 support, appetite, sleep and recovery.
- What the evidence isReal human trials, and they are the reason to be careful rather than excited.
- What to watchNumbness or tingling in the hands.
How MK-677 works
Orally active ghrelin-receptor agonist / GH secretagogue — sustains elevated GH and IGF-1 around the clock.
MK-677 is not growth hormone and it is not a growth hormone releasing hormone analog. It is a non-peptide agonist at the receptor for a stomach hormone, and every distinctive property of the compound — the oral activity, the 24-hour half-life, the hunger, the fluid retention — follows from that one fact.
The receptor. A receptor in pituitary and hypothalamus that functions in growth hormone release was cloned before its natural ligand was known Howard 1996; three years later that ligand was identified as ghrelin, an acylated peptide from the stomach Kojima 1999. The receptor is GHS-R1a.
- Oral
On the goal map: Sleep depth, slow-wave & recovery quality (Sleep better)
Research on MK-6776 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
Real human trials, and they are the reason to be careful rather than excited. A two-year randomized trial in healthy older adults raised IGF-1 to young-adult levels and increased fat-free mass by roughly 1.6 kg — the efficacy signal is not in doubt. The same program showed increased fasting glucose and reduced insulin sensitivity.
Development for frailty was discontinued and a hip-fracture trial stopped early. That is a different kind of failure from a compound that does nothing — it worked, and the metabolic cost was judged not worth it for a frail elderly population on a long-term daily drug. Someone using it in short courses with normal glucose handling is not that population, which is the honest read and also not a license to ignore the finding.
Correlative data
Very widely used, and the reported experience matches the trials closely: marked appetite increase, water retention and improved sleep depth within days, lethargy and puffiness in a substantial minority.
Because it is orally active and long-acting, people run it for months, which is precisely the pattern the glucose data argues against.
How the mechanism reads
An orally-bioavailable ghrelin-receptor agonist with a ~24-hour half-life. Continuous receptor occupancy is the key mechanistic difference from injectable secretagogues — it produces a sustained elevation rather than a pulse, and sustained GH/IGF-1 signaling is what predicts the insulin resistance the trials found.
MechanisticThe same continuous ghrelin signaling predicts the appetite effect, which is a feature if you are trying to gain and a serious problem if you are not.
Mechanistic
Sources
- Colldén G, Tschöp MH, Müller TD. Therapeutic Potential of Targeting the Ghrelin Pathway. International Journal of Molecular Sciences 2017 · PMID 28398233
MK-677 safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Active or past cancer, or a suspected tumor: sustained GH and IGF-1 raise cell growth signaling.
- Type 2 diabetes, prediabetes or insulin resistance: it raises fasting glucose and lowers insulin sensitivity.
- Congestive heart failure: it causes fluid retention.
- Pregnancy, or under 18.
- Sleep apnea: water retention and weight gain can worsen airway narrowing.
What’s expected
- Strong hunger, especially in the first weeks, from ghrelin receptor activation.
- Water retention, puffy hands and a heavier scale weight.
- Deeper, more vivid sleep.
- Higher fasting glucose and lower insulin sensitivity over time.
Watch for
- Numbness or tingling in the hands.
- Rapid swelling of ankles, or breathlessness lying flat.
- Increased thirst and urination.
- Persistent joint or muscle pain.
Labs that tell you it’s working
- IGF-1 (Insulin-like Growth Factor 1)
- Insulin (Fasting)
- HbA1c (Hemoglobin A1c)
- Comprehensive Metabolic Panel (CMP)
Oral GHS-R1a agonist keeping GH and IGF-1 high around the clock; glucose, insulin and fluid effects follow.
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
MK-677 FAQ4 common questions
- Is MK-677 approved for human use?
- No. MK-677 is a research compound.
- What is MK-677 researched for?
- Around-the-clock GH/IGF-1 support, appetite, sleep and recovery.
- Which labs show whether it's doing anything?
- IGF-1; Insulin; HbA1c; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for MK-677: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



